ELISpot and FluoroSpot Assay Market Driven by Vaccine Development Activities

Posted by Apeksha on July 19th, 2021

Global ELISpot and FluoroSpot Assay Market Research Report, by Product (Assay Kit, Ancillary Products), Application (Transplant, Vaccines), End-User (Hospitals and Clinics, Ambulatory Surgical Centres, Diagnostic Centres, Research Centers) – Forecast Till 2027

ELISpot and FluoroSpot assays are techniques which are used to assess the antibody reactivity at the cellular level. They are extensively used by hospitals as well as research institutes for early detection of various diseases, most commonly for tuberculosis or viral infection. FluoroSpot assay is an adaptation of the ELISpot assay and has gained widespread acceptance. Market Research Future (MRFR) has extensively studied the patterns and trends governing the global ELISpot and FluoroSpot assay market over the forecast period of 2018-2023 in a detailed report. MRFR has asserted that the market is likely to reach USD 287 Mn at a splendid CAGR of 16.2% over the forecast period. The market stood at USD 135 Mn in 2017.

Regional Analysis

By region, the global ELISpot and FluoroSpot assay market have been segmented into North America, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/elispot-and-fluorospot-assay-market-6948

Competitive Landscape

Biotech Investissement (France), Becton, Dickinson and Company (US), Lophius Biosciences (Germany), Mabtech (Sweden), U-CyTech (Netherlands), Cellular Technologies (US), Bio-Techne (US), Oxford Immunotec (UK), Autoimmun Diagnostika (Germany), and Abcam (UK) are the distinguished players in the global ELISpot and FluoroSpot market.

You may also be interested in..

Pharmacy Repackaging Systems Market Research Report Global Forecast Till 2027

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com